Covered recipient · General Payments record
ANGELICA TORRES
Nursing Service Providers Registered Nurse Ambulatory Care
General Payments · PY2025
$423.15
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $423.15 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $146.53 | 8 |
| Medtronic, Inc. | $138.09 | 1 |
| SANOFI-AVENTIS U.S. LLC | $83.40 | 4 |
| Neurocrine BioSciences, Inc. | $31.19 | 1 |
| Tandem Diabetes Care, Inc. | $23.94 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $423.15 | 15 |
Payment records · PY2025 (15)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Medtronic, Inc. | $138.09 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220050792 | CMS |
| Neurocrine BioSciences, Inc. | $31.19 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242824499 | CMS |
| Novo Nordisk Inc | $14.70 | 01/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188756049 | CMS |
| Novo Nordisk Inc | $21.46 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188897064 | CMS |
| Novo Nordisk Inc | $13.27 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188488342 | CMS |
| Novo Nordisk Inc | $19.11 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188578362 | CMS |
| Novo Nordisk Inc | $20.93 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188599772 | CMS |
| Novo Nordisk Inc | $24.62 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188495497 | CMS |
| Novo Nordisk Inc | $17.15 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188616311 | CMS |
| Novo Nordisk Inc | $15.29 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188417024 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.16 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233215071 | CMS |
| SANOFI-AVENTIS U.S. LLC | $17.41 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233215093 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.51 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233215129 | CMS |
| SANOFI-AVENTIS U.S. LLC | $27.32 | 11/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233215131 | CMS |
| Tandem Diabetes Care, Inc. | $23.94 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241272917 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.